AI assistant
Axogen, Inc. — Director's Dealing 2024
Jun 11, 2024
32414_dirs_2024-06-10_1a33cb20-ea4f-4c66-8e9e-0a2c5474479f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2024-06-06
Reporting Person: Burke William P. Mr. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-06-06 | Common Stock | A | 10653 | — | Acquired | 16653 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-06-06 | Employee Stock Option (right to purchase) | $7.04 | A | 18248 | Acquired | 2034-06-06 | Common Stock (18248) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
F2: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 6, 2025, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.